- Issuer ticker
-
N/A
- Reported as of
-
02 Nov 2026
- Net transaction value
-
$0
Source evidence
Original filing metadata and source links for verification.
4 source fields
- SEC form
-
4
- Accepted by SEC
-
02 Nov 2026, 16:07:12 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ Isabelle Muldner, Managing Director
Filing notes and source
Key filing fact
Salvia Investment GmbH filed Form 4 for Bambusa Therapeutics, Inc. on 02 Nov 2026.
Key facts
- This page summarizes Salvia Investment GmbH's Form 4 filing for Bambusa Therapeutics, Inc..
- 5 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 02 Nov 2026, 16:07.
Change
- Previous filing in this sequence was filed on 29 Oct 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0002162499
Primary reporting owner
Salvia Investment GmbH
- Relationship
-
10%+ Owner
- Address
- BERGFELDSTR. 9, HOLZKIRCHEN, GERMANY
- Signature
- /s/ Isabelle Muldner, Managing Director
- Signature date
- 02 Nov 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
No ticker
transaction
Common Stock
Conversion of derivative security
- Transaction value
- Shares
- +4,769,701
- Change %
- +116%
- Price
-
- Shares after
- 8,889,301
- Date
- 02 Nov 2026
- Ownership
- Direct
- Footnotes
- F1
No ticker
transaction
Common Stock
Purchase
- Transaction value
- Shares
- +375,000
- Change %
- +4.2%
- Price
-
$16.00*
- Shares after
- 9,264,301
- Date
- 02 Nov 2026
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
No ticker
transaction
Derivative
Series Seed Plus Preferred Stock
Conversion of derivative security
- Transaction value
- Shares
- -3,135,066
- Change %
- -100%
- Price
-
$0.000000*
- Shares after
- 0
- Date
- 02 Nov 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,135,066
- Exercise price
- Footnotes
- F1
No ticker
transaction
Derivative
Series A-1 Preferred Stock
Conversion of derivative security
- Transaction value
- Shares
- -1,473,775
- Change %
- -100%
- Price
-
$0.000000*
- Shares after
- 0
- Date
- 02 Nov 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,473,775
- Exercise price
- Footnotes
- F1
No ticker
transaction
Derivative
Series A-2 Preferred Stock
Conversion of derivative security
- Transaction value
- Shares
- -160,860
- Change %
- -100%
- Price
-
$0.000000*
- Shares after
- 0
- Date
- 02 Nov 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 160,860
- Exercise price
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote